Vistin Pharma Investor Relations Material
Latest events
Q2 2024
Vistin Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Vistin Pharma
Access all reports
Segment Data
Access more data
Revenue by
Geography
Europe
Africa
North and South America
Asia
Expenses by
Financials
Vistin Pharma AS is a global pharmaceutical company that produces and markets active pharmaceutical ingredients. The company offers its products to an extensive network of third party manufacturers. In addition, the company develops its own formulations that are produced and marketed by the Vistin Pharma AS subsidiary. As well as producing bulk APIs, Vistin Pharma has a wide range of products in different stages of development that it expects will be launched in 2016.
Vistin Pharma has experienced continued growth in demand for its products, both due to the expansion of the pharma industry and from the increasing amount of specialised niche pharmaceuticals being developed. Its focus is on supplying products for diabetes and autoimmunity therapies as well as antibiotics. The company was incorporated in 2015 and is headquartered in Oslo, Norway.
Key slides for Vistin Pharma
Q4 2023
Vistin Pharma
Q2 2024
Vistin Pharma
Latest articles
Cristiano Amon: Qualcomm's 5G Specialist CEO
Cristiano Amon, Qualcomm CEO, has spent two decades at the company while taking on several roles, developing both technical and business expertise.
16 Sep 2024
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Ticker symbol
VISTN
Country
🇳🇴 Norway